GLSHQ — Gelesis Holdings Share Price
0.000.00%
Last trade - 00:00- $0.00m
- $65.63m
- $25.77m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -343.14% | ||
| Return on Equity | n/a | ||
| Operating Margin | -546.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 21.44 | 11.19 | 25.77 | 51.38 | 80.92 | 9.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- February 14th, 2020
- Public Since
- July 7th, 2020
- No. of Shareholders
- 35
- No. of Employees
- 93
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 73,335,110
- Address
- 501 Boylston Street, Suite 6102, BOSTON, 02116
- Web
- https://capstarspac.com/
- Phone
- +1 8573277737
- Auditors
- KPMG LLP
Upcoming Events for GLSHQ
Q1 2024 Gelesis Holdings Inc Earnings Release
Q2 2024 Gelesis Holdings Inc Earnings Release
Similar to GLSHQ
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
What is the Gelesis Holdings share price?
As of Today at 20:50 UTC, shares in Gelesis Holdings are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Gelesis Holdings share price performed this year?
Shares in Gelesis Holdings last closed at $0.00 and the price had moved by -100% over the past 365 days. In terms of relative price strength the Gelesis Holdings share price has underperformed the S&P500 Index by -100% over the past year.
What are the analyst and broker recommendations for Gelesis Holdings?
The overall consensus recommendation for Gelesis Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Gelesis Holdings dividend yield?
Gelesis Holdings does not currently pay a dividend.
Does Gelesis Holdings pay a dividend?
Gelesis Holdings does not currently pay a dividend.
When does Gelesis Holdings next pay dividends?
Gelesis Holdings does not currently pay a dividend.
How do I buy Gelesis Holdings shares?
To buy shares in Gelesis Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Gelesis Holdings?
As of the previous close price of $0.00, shares in Gelesis Holdings had a market capitalisation of $0.00m.
Where are Gelesis Holdings shares listed?
Here are the trading details for Gelesis Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: GLSHQ
What kind of share is Gelesis Holdings?
Based on an overall assessment of its quality, value and momentum Gelesis Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Gelesis Holdings share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Gelesis Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Gelesis Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -99.98%.
As of the last closing price of $0.00, shares in Gelesis Holdings were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Gelesis Holdings PE Ratio?
The Gelesis Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Gelesis Holdings?
We do not have data on Gelesis Holdings' directors